References
- Ihle B U, Long P, Oats J. Early onset pre‐eclampsia: recognition of underlying renal disease. Br Med J 1987; 294: 79–81
- Rennke H C, Venkatachalam M A. Glomerular permeability: in vivo tracer studies with polyanionic and polycationic ferritins. Kidney Int 1977; 11: 44–53
- Brenner B M, Hostetter T H, Humes H D. Molecular basis of proteinuria of glomerular origin. N Engl J Med 1978; 298: 826–33
- Kanwar Y S, Linker A, Farquhar M G. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. J Cell Biol 1980; 86: 688–93
- Rosenweig L J, Kanwar Y S. Removal of sulphated (heparan sulphate) or non‐sulphated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to l2:I‐bovine serum albumin. Lab Invest 1982; 47: 177–84
- Kelley V E, Cavallo T. Glomerular permeability: transfer of native ferritin in glomeruli with decreased anionic sites. Lab Invest 1978; 39: 547–53
- Hunsicker L G, Shearer T P, Schaffer S J. Acute reversible proteinuria induced by infusion of the polycation hexadimethrine. Kidney Int 1981; 20: 7–17
- Barnes J L, Radnik R A, Gilchrist E R, Venkatachalam M A. Size and charge selective permeability defects induced in glomerular basement membrane by a polycation. Kidney Int 1984; 25: 11–19
- Michael A F, Blau E, Vernier R L. Glomerular polyanion: alteration in aminonucleo‐side nephrosis. Lab Invest 1970; 23: 649–57
- Carrie B J, Salyer W R, Myers B D. Minimal change nephropathy: an electrochemical disorder of the glomerular membrane. Am J Med 1981; 70: 262–8
- Vernier R L, Steffes M W, Sisson‐Ross S, Mauer S M. Heparan sulphate proteoglycan in the glomerular basement membrane in type I diabetes mellitus. Kidney Int 1992; 41: 1070–80
- Moodley J. Hypertension in pregnancy. S Afr J Cont Med Educ 1991; 9: 72–80
- Moodley J, Naicker R S, Mankowiiz E. Eclampsia–a method of management. S Afr Med J 1983; 63: 530–5
- Mahan J D, Sisson‐Ross S, Vernier R L. Glomerular basement membrane anionic charge site changes early in aminonucleoside nephrosis. Am J Pathol 1986; 125: 393–401
- Randeree G H, Ramjee G, Moodley J. Altered erythrocyte charge in African women with early‐onset preeclampsia. Hypertens Pregnancy 1994; 13(2)193–9
- Candiano G, Ghiggeri G M, Oleggini R, Ginevri F, Altieri P, Gusmano R. Interaction between cationic dyes and erythrocyte membranes in minimal change nephropathy: an electrophoretic approach. Pediatr Nephrol 1991; 5: 173–8
- Kanwar Y S, Veis A, Kimura J H, Jakubowski M L. Characterisation of heparan sulphate proteoglycan of the glomerular basement membranes. Proc Natl Acad Sci USA 1984; 81: 762–6
- Bernard A M, Ouled A, Cardenas A, Lauwerys R R. Validity of the alcian blue binding test as an indicator of red blood cell and glomerular membrane negative charges. Nephron 1989; 52: 184–5
- Rada J A, Carlson E C. Electron microscopic histochemical and immunochemical analysis of heparan sulphate proteoglycan distribution in renal glomerular basement membranes. Histol Histopathol 1991; 6: 149–60
- Kanwar Y S, Farquhar M G. Anionic sites in the glomerular basement membrane: in vivo and in vitro localisation to the laminae rarae by cationic probes. J Cell Biol 1979; 81: 137–53
- Van den Heuvel L PWJ, Ban den Born J, Jalanko H, Schroder C H, Veerkamp J H, Assman K J M, Berden J H M, Holmberg C, Rapola J, Monnens L A H. The glycos‐aminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 1992; 6: 10–15
- Laurie C W, Kleinman H K, Hassel J R, Martin G R, Feldman R J. Basement membrane organizations suggested by combination of laminin and heparan sulphate proteoglycan binding sites with the “open network” and “polygonal” models of type IV collagen [abstract]. J Cell Biol 1985; 101: 259a
- Yurchenko P D, Tsilibary E C, Charanois A S, Furthmayr H. Models for the self assembly of basement membrane. J Histochem Cytochem 1986; 34: 93–102
- Vermylen C, Levin M, Mossman J, Barrat T M. Glomerular and urinary heparan sulphate in congenital nephotic syndrome. Pediatr Nephrol 1989; 3: 122–9